PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Acrivastine - Allergic rhinitis
PAD Profile : Acrivastine - Allergic rhinitis
Keywords :
Hay fever, hayfever, antihistamines, allergy, seasonal allergic rhinitis, pollen allergy, non-sedating antihistamines
Brand Names Include :
Benadryl allergy relief
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Cetirizine hydrochloride
- Loratadine
- Desloratadine
- Levocetirizine
- Bilastine
- Mizolastine
- Fexofenadine hydrochloride
- Rupatadine fumarate
- House dust mites allergen extract
- White Birch pollen allergen extract
- Chlorphenamine maleate
- Ketotifen fumarate
- Promethazine hydrochloride
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Acrivastine capsules need to be taken three times a day and are therefore less desirable from an adherence to therapy perspective.
It is also considered to be less cost effective and is therefore not recommended as a routine treatment option in local guidelines - see below.
Available to purchase over the counter
Associated BNF Codes
03. Respiratory System
03.04.01. Antihistamines